David Blank

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

May Faraj, Peter J. Havel, Steve Phélis et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 505 citations · Full text

Novel Reductant for Determination of Total Plasma Homocysteine

Brian M. Gilfix, David Blank, David S. Rosenblatt · Clinical Chemistry · 1997 · 166 citations · Full text

Engineering, Total Hcy, Molecular Pharmacology +16

Automated determination of urinary creatinine without sample dilution: theory and practice.

Martin Kroll, R Chesler, C Hagengruber et al. · Clinical Chemistry · 1986 · 126 citations

Sample Dilution, Urology, Renal Function +15